These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4870988)

  • 1. A clinical trial of a-methyl-para-tyrosine in mentally ill patients.
    Charalampous KD; Brown S
    Psychopharmacologia; 1967 Oct; 11(5):422-9. PubMed ID: 4870988
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-methyl-p-tyrosine (AMT) in schizophrenia.
    Gershon S; Hekimian LJ; Floyd A; Hollister LE
    Psychopharmacologia; 1967; 11(2):189-94. PubMed ID: 5588188
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical measurement of the function of the adrenal medulla and sympathetic system in the clinic].
    Jéquier E
    Schweiz Med Wochenschr; 1970 Mar; 100(12):532-6. PubMed ID: 4906883
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of extra-adrenal pheochromocytoma treated with alpha-methyl-p-tyrosine].
    Torres Zamora M; Girón N; Ortiz Quezada F; Serrano P
    Arch Inst Cardiol Mex; 1972; 42(1):113-21. PubMed ID: 4401165
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of alpha-methyl-para-tyrosine, L-dopa, and L-tryptophan in depression and mania.
    Bunney WE; Brodie HK; Murphy DL; Goodwin FK
    Am J Psychiatry; 1971 Jan; 127(7):872-81. PubMed ID: 4924778
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-methyl-p-tyrosine in the symptomatic treatment of patients with malignant phaeochromocytoma.
    Pyörälä K; Pitkänen E; Toivonen S
    Ann Med Intern Fenn; 1968; 57(2):65-73. PubMed ID: 5706389
    [No Abstract]   [Full Text] [Related]  

  • 7. Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism.
    Brodie HK; Murphy DL; Goodwin FK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):218-24. PubMed ID: 5554938
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and pharmacologic effects of alpha-methyltyrosine in man.
    Engelman K; Horwitz D; Jéquier E; Sjoerdsma A
    J Clin Invest; 1968 Mar; 47(3):577-94. PubMed ID: 5637145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha-methyl-paratyrosine in the treatment of malignant pheochromocytoma].
    Decoulx M; Wemeau JL; Racadot-Leroy N; Grimbert I; Proye C; Plane C
    Rev Med Interne; 1987; 8(4):383-8. PubMed ID: 3423477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-potentiating effect of metyrosine.
    Magelund G; Gerlach J; Casey DE
    Am J Psychiatry; 1979 May; 136(5):732. PubMed ID: 35016
    [No Abstract]   [Full Text] [Related]  

  • 11. Catecholamines in turkeys with high or low blood pressure: effects of tyrosine hydroxylase inhibitor and ganglionic blocker.
    el-Halawani ME; Waibel PE; Appel JR; Good AL; Duke GE
    Can J Physiol Pharmacol; 1972 Jul; 50(7):697-702. PubMed ID: 4403223
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased catecholamine excretion in the rat after administration of alpha-methyl-tyrosine.
    Beauvallet M; Roffi J; Giudicelli Y; Legrand-Tissot M
    Experientia; 1975 Jun; 31(6):672-4. PubMed ID: 1140290
    [No Abstract]   [Full Text] [Related]  

  • 13. Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Effects of alpha methyl para tyrosine and tetrabenazine.
    Sweet RD; Bruun R; Shapiro E; Shapiro AK
    Arch Gen Psychiatry; 1974 Dec; 31(6):857-61. PubMed ID: 4613321
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic-potentiating effect of alpha-methyl-p-tyrosine compared with haloperidol and placebo in a double-blind cross-over trial.
    Magelund G; Gerlach J; Casey DE
    Acta Psychiatr Scand; 1979 Aug; 60(2):185-9. PubMed ID: 41413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.
    Engelman K; Jéquier E; Udenfriend S; Sjoerdsma A
    J Clin Invest; 1968 Mar; 47(3):568-76. PubMed ID: 5637144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pheochromocytoma: urinary catecholamine excretion and insulin secretion after -methyl-p-tyrosine treatment.
    Parra A; Porcayo F; Santos D
    Helv Paediatr Acta; 1972 Jul; 27(3):309-14. PubMed ID: 4645656
    [No Abstract]   [Full Text] [Related]  

  • 17. Childhood pheochromocytoma: treatment with alpha methyl tyrosine for resistant hypertension.
    Robinson RG; DeQuattro V; Grushkin CM; Lieberman E
    J Pediatr; 1977 Jul; 91(1):143-7. PubMed ID: 17659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
    Tcherdakoff P; Ménard J; Bedrossian J; Vaysse J; Alexandre JM; Milliez P
    Sem Hop; 1972 May; 48(25):1779-87. PubMed ID: 4405188
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of alpha-methyl-paratyrosine on the urinary excretion of catecholamines in patients with pheochromocytoma].
    Rivero Sánchez M; Selgas Gutiérrez R; Lorenzo Aguiar MD; Martínez Muñoz I; Beberide García JM; Almaraz Jiménez M; Rińon Aguilar C; Sánchez Sicilia L
    Rev Clin Esp; 1981 May; 161(4):235-9. PubMed ID: 7280330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Alpha-methyl -para-tyrosine in the prolonged treatment of malignant pheochromocytoma and preoperative care of benign pheochromocytoma: preliminary study].
    Tcherdakoff P; Menard J; Bedrossian J; Vaysse J; Alexandre JM; Desmonts JM; Milliez P
    J Urol Nephrol (Paris); 1972 Sep; 78(9):744-7. PubMed ID: 4660655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.